US Backs Away from Blanket Laptop Ban, Imposes New Airline Security Regime Instead
The US pressing tougher security rules– including a bigger role for US agents– under threat of imposing a total ban on laptops in aircraft.
Read more...The US pressing tougher security rules– including a bigger role for US agents– under threat of imposing a total ban on laptops in aircraft.
Read more...Some examples of stranded funds as yet another way of degrading the customer experience.
Read more...EPA administrator Scott Pruitt announces plans to rescind the Clean Water Rule, bowing to developers and other business interests.
Read more...Report recognizes rationale for right to repair, via tweaks to existing rule-making procedures under existing copyright statutory framework.
Read more...The UK rejects the idea of rewarding whistleblowers, despite the fact that the US experience shows it to be a sound way to catch abuses.
Read more...It’s getting harder to ignore the stench coming from the Italian banking system.
Read more...More on the upheaval at Uber.
Read more...CFPB report details errors and practices of student loan servicers that will bar borrowers from qualifying for debt forgiveness.
Read more...Uber is over. But since many have money and reputations at stake, and Uber has cash to burn, it will take a while for that to be undeniable.
Read more...An update on the Eurozone banking mess.
Read more...State probes of opioid manufacturers may loom large, especially if Trump’s Justice Department eschews targeting corporate crime.
Read more...Congressional Democrats file yet another emoluments clause lawsuit today; lack of standing will prevent assessing its claims on the merits.
Read more...Banks are champing at the bit to get Dodd Frank “reform,” when for many, the changes will actually increase their costs.
Read more...Trump and the Republicans are moving forward with deregulation plans that serve big bank bottom lines, not the broader economy.
Read more...Why Democratic voters need to turf out Senators who put the profits of drug companies above their constituents’ needs.
Read more...